Top Markets
Coin of the day
OrbusNeich Medical Group Holdings Limited OrbusNeich Medical Group Holdings Limited

OrbusNeich Medical Group Holdings Limited

6929
Pozycja w akcjach #14346
OrbusNeich Medical Group Holdings Limited functions as an investment holding... OrbusNeich Medical Group Holdings Limited functions as an investment holding entity, specializing in the development, distribution, sales, and marketing of medical instruments tailored for treating coronary and peripheral vascular ailments. The company boasts a significant international presence, serving markets across Japan, Europe, the Middle East, Africa, the Asia Pacific region, the People's Republic of China, and the United States. Its product offerings encompass a range of essential devices, including semi-compliant and scoring balloons used for initial vessel preparation, coronary stents for implantation, non-compliant balloons designed for post-dilatation, and a variety of specialized catheters. This extensive portfolio of products addresses critical steps within percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. Founded in 2001, the company is headquartered in Shatin, Hong Kong, and operates as a subsidiary of Harmony Tree Limited.
Cena akcji
$0.51170492
Kapitalizacja rynkowa
$421.26M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-11.73%
Kraj
HK
Handel OrbusNeich Medical Group Holdings Limited (6929)

Kategoria

Zyski dla OrbusNeich Medical Group Holdings Limited (6929)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych OrbusNeich Medical Group Holdings Limited, obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy OrbusNeich Medical Group Holdings Limited od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
$3.81B -
US
$4.11B -
FR
- -
JP
$1.59B -
US
- -
CH